Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Helena, Katchman"'
Autor:
Yuval Ishay, Joel Neutel, Yotam Kolben, Ram Gelman, Orly Sneh Arbib, Oliver Lopez, Helena Katchman, Rizwana Mohseni, Miriam Kidron, Yaron Ilan
Publikováno v:
Gastro Hep Advances, Vol 3, Iss 3, Pp 417-425 (2024)
Background and Aims: Metabolic dysfunction-associated steatohepatitis is an advanced form of nonalcoholic fatty liver disease and a leading cause of end-stage liver disease and transplantation. Insulin resistance and inflammation underlie the pathoge
Externí odkaz:
https://doaj.org/article/16e26c8066314c3a88ab48b36bbb82c7
Autor:
Rinat Lasmanovich, Or Shaked, Ayelet Sivan, Idan Barak, Mor Nahari, Orna Mor, Helena Katchman
Publikováno v:
Substance Abuse: Research and Treatment, Vol 16 (2022)
Background: Hepatitis C virus (HCV) infection is a primary health concern among people who use drugs (PWUDs). Homeless PWUDs that constitute a key population for HCV transmission remain underrepresented in many surveys. Objectives: We performed a pro
Externí odkaz:
https://doaj.org/article/3be4a96344a44bbdaa717db37ac4a3cf
Autor:
Liat Deutsch, Inbal Houri, Ziv Ben-Ari, Amir Shlomai, Ella Veitsman, Oranit Cohen-Ezra, Assaf Issachar, Orna Mor, Yael Gozlan, Rafael Bruck, Yoram Menachem, Shira Zelber-Sagi, Helena Katchman, Oren Shibolet
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Hepatitis C virus (HCV) infection is a leading cause of chronic liver disease and hepatocellular carcinoma. Treatment with first generation protease inhibitors (PI) + peg-interferon (pegIFN) and ribavirin (RBV) achieved sustained
Externí odkaz:
https://doaj.org/article/8d8a09a64891489ca8134d6425a34e9c
Autor:
Helena, Katchman, Miriam, Adelson, Oren, Avitan, Mira, Mattatov, Anat, Sason, Stela, Levitt, Lior, Dvorak, Shaul, Schreiber, Einat, Peles
Publikováno v:
Journal of Addiction Medicine. 16:e350-e355
Patient ignorance and bureaucratic obstacles prevent initiation of hepatitis C virus (HCV) treatment in patients participating in methadone treatment program. Despite high safety and efficacy of currently available oral medications, the rate of patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37feed096450ba7f5f37d5ee3e098462
https://doi.org/10.1097/adm.0000000000000975
https://doi.org/10.1097/adm.0000000000000975
Autor:
Ayelet Grupper, Liane Rabinowich, Merav Ben-Yehoyada, Eugene Katchman, Roni Baruch, Tal Freund, David Hagin, Shani Ben Shlomo, Doron Schwartz, Idit F. Schwartz, Moshe Shashar, Orit Kliuk-Ben Bassat, Tami Halperin, Dan Turner, Esther Saiag, Yaacov Goykhman, Oren Shibolet, Sharon Levy, Inbal Houri, Helena Katchman
Publikováno v:
Transplantation Proceedings. 54:1439-1445
Most solid organ transplant recipients did not develop an appreciable serologic response after 2 doses of the mRNA SARS-CoV-2 vaccine.We analyzed the humoral response after a third dose of the BNT162b2 vaccine in 130 kidney transplant recipients, com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a68a5c0d30e599f8fefb424340d784e
https://doi.org/10.1016/j.transproceed.2022.02.011
https://doi.org/10.1016/j.transproceed.2022.02.011
Autor:
Nir Bar, Noa Bensoussan, Liane Rabinowich, Sharon Levi, Inbal Houri, Dana Ben-Ami Shor, Oren Shibolet, Orna Mor, Ella Weitzman, Dan Turner, Helena Katchman
Publikováno v:
International Journal of Environmental Research and Public Health; Volume 19; Issue 22; Pages: 15237
Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) are often co-transmitted. Viral coinfection results in worse outcomes. Persons who inject drugs (PWIDs) face barriers to medical treatment, but HCV treatment is indicated and effective ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32e1ff415dfc511d4d55095da164f0d7
Autor:
Helena Katchman, Ido Nachmany, Liane Rabinowich, Sharon Levy, N. Gotlieb, Yaacov Goykhman, Oren Shibolet, O. Gilad, P. Katz, Nir Lubezky
Publikováno v:
Transplantation Proceedings. 53:221-227
Background Mammalian target of rapamycin (mTOR) inhibitors following liver transplantation (LT) are used to minimize calcineurin inhibitor (CNI)-related nephrotoxicity. Data about metabolic effects of mTOR inhibitors are still limited. Aim This study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58cd099ca8e8e22730ca74824d953ca9
https://doi.org/10.1016/j.transproceed.2020.05.021
https://doi.org/10.1016/j.transproceed.2020.05.021
Autor:
Stephen A. Harrison, Federico Perez Manghi, William B. Smith, Diana Alpenidze, Diego Aizenberg, Naomi Klarenbeek, Chi-Yi Chen, Eli Zuckerman, Eric Ravussin, Phunchai Charatcharoenwitthaya, Pin-Nan Cheng, Helena Katchman, Samuel Klein, Ziv Ben-Ari, Anisha E. Mendonza, Yiming Zhang, Miljen Martic, Shenglin Ma, Sheena Kao, Sandra Tanner, Alok Pachori, Michael K. Badman, YanLing He, Chinweike Ukomadu, Eric Sicard
Publikováno v:
Nat Med
Nonalcoholic steatohepatitis (NASH) is a common chronic liver disease that may advance to fibrosis and lead to mortality; however, no pharmacotherapy is currently available. We tested the hypothesis that inhibition of both the sodium-glucose cotransp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e75d88194984d7468a9e9fe7ccab93e
https://europepmc.org/articles/PMC10061496/
https://europepmc.org/articles/PMC10061496/
Autor:
Ayelet Grupper, Aviad Rabinowich, Idan Ben Shabat, Roie Tzadok, Doron Schwartz, Idit F. Schwartz, Yaacov Goykhman, Orit Kliuk Ben-Bassat, Roni Baruch, Moshe Shashar, Keren Cohen-Hagai, Helena Katchman
Publikováno v:
American journal of nephrology. 53(8-9)
Introduction: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality after kidney transplantation. Metabolic syndrome is common in renal transplant recipients and is associated with increased CVD risk in those patients. Nonalcoh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4725a50af482a33279c8c5ec44ec1990
https://pubmed.ncbi.nlm.nih.gov/36075195
https://pubmed.ncbi.nlm.nih.gov/36075195
Autor:
Yael Weksler, Inbal Houri, Liat Deutsch, Helena Katchman, Ofer Miller, Noya Horowitz, Oren Shibolet
Publikováno v:
World Journal of Gastroenterology
Background Hepatitis C virus (HCV) infection is a leading cause of chronic liver disease worldwide. New treatments for HCV revolutionized management and prompted the world health organization to set the goal of viral elimination by 2030. These develo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::908849e16132207418acf6ea180c9f10
http://europepmc.org/articles/PMC7459203
http://europepmc.org/articles/PMC7459203